1. Home
  2. CYBN vs MYPS Comparison

CYBN vs MYPS Comparison

Compare CYBN & MYPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CYBN
  • MYPS
  • Stock Information
  • Founded
  • CYBN 2019
  • MYPS 2011
  • Country
  • CYBN Canada
  • MYPS United States
  • Employees
  • CYBN N/A
  • MYPS N/A
  • Industry
  • CYBN Pharmaceuticals and Biotechnology
  • MYPS EDP Services
  • Sector
  • CYBN Health Care
  • MYPS Technology
  • Exchange
  • CYBN Nasdaq
  • MYPS Nasdaq
  • Market Cap
  • CYBN 178.7M
  • MYPS 175.7M
  • IPO Year
  • CYBN N/A
  • MYPS N/A
  • Fundamental
  • Price
  • CYBN $7.54
  • MYPS $1.09
  • Analyst Decision
  • CYBN Strong Buy
  • MYPS Buy
  • Analyst Count
  • CYBN 4
  • MYPS 6
  • Target Price
  • CYBN $85.00
  • MYPS $2.80
  • AVG Volume (30 Days)
  • CYBN 412.3K
  • MYPS 257.4K
  • Earning Date
  • CYBN 08-12-2025
  • MYPS 08-04-2025
  • Dividend Yield
  • CYBN N/A
  • MYPS N/A
  • EPS Growth
  • CYBN N/A
  • MYPS N/A
  • EPS
  • CYBN N/A
  • MYPS N/A
  • Revenue
  • CYBN N/A
  • MYPS $274,310,000.00
  • Revenue This Year
  • CYBN N/A
  • MYPS N/A
  • Revenue Next Year
  • CYBN N/A
  • MYPS $0.89
  • P/E Ratio
  • CYBN N/A
  • MYPS N/A
  • Revenue Growth
  • CYBN N/A
  • MYPS N/A
  • 52 Week Low
  • CYBN $4.81
  • MYPS $1.08
  • 52 Week High
  • CYBN $13.88
  • MYPS $2.29
  • Technical
  • Relative Strength Index (RSI)
  • CYBN 46.24
  • MYPS 30.68
  • Support Level
  • CYBN $7.26
  • MYPS $1.18
  • Resistance Level
  • CYBN $7.81
  • MYPS $1.24
  • Average True Range (ATR)
  • CYBN 0.45
  • MYPS 0.07
  • MACD
  • CYBN -0.04
  • MYPS -0.01
  • Stochastic Oscillator
  • CYBN 17.72
  • MYPS 4.35

About CYBN Cybin Inc.

Cybin Inc is a biopharmaceutical company involved in creating safe and effective therapeutics for patients to address a multitude of mental health issues. The Company is a clinical-stage neuropsychiatric company focused on advancing therapies, delivery mechanisms, novel compounds, and protocols as potential treatments for various psychiatric and neurological conditions. The Company is developing technologies and delivery systems aimed at improving the pharmacokinetics of its proprietary molecules while retaining the therapeutic benefit. These new molecules and delivery systems are expected to be studied through clinical trials to confirm safety and efficacy.

About MYPS PLAYSTUDIOS Inc.

PLAYSTUDIOS Inc is engaged in gaming and related business. The Company develops and operates online and mobile social gaming applications (games or game), many of which incorporate a loyalty program offering real world rewards provided by a collection of awards partners. The Company's games are free-to-play and available via the Apple App Store, Google Play Store, Amazon Appstore and Facebook (collectively, platforms or platform operators). The Company creates games based on its own original content as well as third-party licensed brands. The Company generates revenue through the in-game sales of virtual currency and through advertising. The company has one operating segment with one business activity, developing and monetizing social games.

Share on Social Networks: